The global pharmaceutical market is expected to reach sales of nearly $1.1 trillion by 2015, marked by slowing growth in developed markets and strong sales in emerging markets.Latest data from the global pharma industry shows digital spends spent amounted to $2.5 billion channels including pharma company websites, social media, web banner advertising in professional online journals and mobile apps. That works out to be approximately 6% of the total audited marketing expenditure, which includes "traditional, personal promotional channels;" i.e., sales reps.
The chart shows the marketing budgets and Research and development budget for pharma industry top 3 giants. Johnson and Johnson spends the highest on marketing and sales, with over $15billion, while RD spends for the brand accounts of over $8billion.
Both Novartis and Pfizer spends higher on sales and marketing as compared to research and development with $14billion and $12billion respectively, while RD spends by Novartis is $10billion and $7billion
No comments:
Post a Comment